Stockscreener 앱 받기
2.45
2.51%
0.06
시간 외 거래:
2.45
전일 마감가:
$2.39
열려 있는:
$2.43
하루 거래량:
374.28K
Relative Volume:
1.24
시가총액:
$257.77M
수익:
$7.05M
순이익/손실:
$-30.43M
주가수익비율:
-6.4678
EPS:
-0.3788
순현금흐름:
$21.84M
1주 성능:
+8.89%
1개월 성능:
+15.84%
6개월 성능:
+20.10%
1년 성능:
+29.97%
1일 변동 폭
$2.36
$2.50
1주일 범위
$2.22
$2.50
52주 변동 폭
$1.07
$4.62
Proqr Therapeutics N V Stock (PRQR) Company Profile
PRQR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
2.45 | 251.77M | 7.05M | -30.43M | 21.84M | -0.3788 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-04-29 | 개시 | Evercore ISI | Outperform |
| 2025-03-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-29 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-02-01 | 개시 | Raymond James | Strong Buy |
| 2021-05-03 | 개시 | Stifel | Buy |
| 2021-03-25 | 재확인 | Citigroup | Buy |
| 2020-11-03 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-03-12 | 재확인 | Chardan Capital Markets | Buy |
| 2018-12-19 | 개시 | RBC Capital Mkts | Outperform |
| 2018-11-15 | 개시 | Citigroup | Buy |
| 2018-09-19 | 개시 | Evercore ISI | Outperform |
| 2017-09-26 | 재확인 | JMP Securities | Mkt Outperform |
| 2016-06-20 | 개시 | Chardan Capital Markets | Neutral |
| 2014-10-15 | 개시 | Deutsche Bank | Buy |
| 2014-10-13 | 개시 | H.C. Wainwright | Buy |
모두보기
Proqr Therapeutics N V 주식(PRQR)의 최신 뉴스
Can technical indicators confirm ProQR Therapeutics N.V.’s reversal2025 Price Targets & AI Enhanced Trading Signals - Newser
ProQR Therapeutics: Not A Needle Mover Just Yet - Seeking Alpha
What is ProQR Therapeutics N.V.’s book value per shareProfit Target & Safe Swing Trade Setup Alerts - خودرو بانک
Intraday pattern recognizer results for ProQR Therapeutics N.V.Analyst Downgrade & Smart Allocation Stock Tips - Newser
Can trapped investors hope for a rebound in ProQR Therapeutics N.V.July 2025 Reactions & Verified Stock Trade Ideas - Newser
What are ProQR Therapeutics N.V.’s recent SEC filings showingJuly 2025 Decliners & Verified Entry Point Detection - خودرو بانک
What to expect from ProQR Therapeutics N.V. in the next 30 daysQuarterly Performance Summary & Community Trade Idea Sharing Platform - Newser
Can ProQR Therapeutics N.V. generate free cash flowProduct Launch & Free Expert Verified Stock Movement Alerts - خودرو بانک
Sentiment Recap: What is the target price for ProQR Therapeutics N.V. stockRate Cut & Stepwise Trade Signal Implementation - خودرو بانک
Is ProQR Therapeutics N.V. meeting your algorithmic filter criteriaPortfolio Return Report & Real-Time Stock Movement Alerts - Newser
Can ProQR Therapeutics N.V. be recession proofJuly 2025 Big Picture & Growth Focused Investment Plans - خودرو بانک
How hedge fund analytics apply to ProQR Therapeutics N.V. stockJuly 2025 Volume & Consistent Growth Equity Picks - Newser
Is ProQR Therapeutics N.V. likely to announce a buyback2025 Key Lessons & Growth Focused Stock Pick Reports - beatles.ru
Is ProQR Therapeutics N.V. stock ready for a breakoutJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
Real time breakdown of ProQR Therapeutics N.V. stock performancePortfolio Return Report & Weekly High Momentum Picks - Newser
Retinitis Pigmentosa Market to Evolve Rapidly Over the Next - openPR.com
Is ProQR Therapeutics N.V. undervalued by DCF analysisMarket Volume Report & Smart Investment Allocation Tips - خودرو بانک
Should you buy the dip on ProQR Therapeutics N.V.2025 Year in Review & Verified Momentum Stock Ideas - خودرو بانک
Candlestick signals on ProQR Therapeutics N.V. stock todayQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - Newser
Building trade automation scripts for ProQR Therapeutics N.V.Weekly Volume Report & Safe Entry Point Alerts - Newser
Is ProQR Therapeutics N.V. a potential multi bagger2025 Macro Impact & Short-Term High Return Ideas - خودرو بانک
Momentum divergence signals in ProQR Therapeutics N.V. chartJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Can ProQR Therapeutics N.V. hit a new high this monthJuly 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
Chart based analysis of ProQR Therapeutics N.V. trendsLong Setup & Risk Controlled Swing Alerts - Newser
Will ProQR Therapeutics N.V. benefit from current market trendsJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - khodrobank.com
Pullback Watch: Can ProQR Therapeutics N.V. be recession proofWeekly Stock Recap & Accurate Entry and Exit Point Alerts - خودرو بانک
What high frequency data says about ProQR Therapeutics N.V.2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
What Fibonacci levels say about ProQR Therapeutics N.V. reboundJuly 2025 Snapshot & Low Drawdown Momentum Trade Ideas - Newser
Is it too late to sell ProQR Therapeutics N.V.2025 Trade Ideas & Fast Gain Stock Tips - Newser
ProQR Therapeutics N.V. stock trend outlook and recovery pathQuarterly Profit Review & Technical Pattern Based Signals - Newser
ProQR Therapeutics N.V. recovery potential after sell off2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - Newser
Can ProQR Therapeutics N.V. recover in the next quarterJuly 2025 Trends & Low Risk Growth Stock Ideas - Newser
Buy Signal: What are ProQR Therapeutics N.V.’s recent SEC filings showingM&A Rumor & Growth Focused Investment Plans - خودرو بانک
How cyclical is ProQR Therapeutics N.V.’s revenue streamGlobal Markets & Verified Entry Point Detection - خودرو بانک
Movement Recap: Can ProQR Therapeutics N.V. be recession proofJuly 2025 Update & High Accuracy Trade Signal Alerts - خودرو بانک
Is ProQR Therapeutics N.V. benefiting from innovation trendsAnalyst Downgrade & Precise Entry and Exit Recommendations - خودرو بانک
Can ProQR Therapeutics N.V. reach resistance levels soon2025 Market Outlook & Growth-Oriented Investment Plans - خودرو بانک
What is the earnings history of ProQR Therapeutics N.V.July 2025 Rallies & Daily Profit Focused Stock Screening - خودرو بانک
Research Analysts Issue Forecasts for PRQR FY2025 Earnings - MarketBeat
Is ProQR Therapeutics N.V. building a consolidation baseMarket Growth Report & Daily Market Momentum Tracking - Newser
Will ProQR Therapeutics N.V. price bounce be sustainable2025 Fundamental Recap & Accurate Entry/Exit Alerts - Newser
What’s the RSI of ProQR Therapeutics N.V. stockTrade Exit Summary & High Conviction Buy Zone Picks - خودرو بانک
Proqr Therapeutics N V (PRQR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):